Akribion Therapeutics
Pre-clinicalSpecific, versatile, effective RNA-guided cell depletion
Founded
2021
Focus
OncologySmall Molecules
About
Specific, versatile, effective RNA-guided cell depletion
Funding History
1Total raised: $4.5M
Seed$4.5MHigh-Tech GründerfondsSep 15, 2021
Company Info
TypePrivate
Founded2021
LocationMunich, Germany
StagePre-clinical
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile